Page 18 - Sanket Koul

Younger population seeing high rates of infection amid Covid surge: Experts

According to data available on the Union health ministry's Covid dashboard, India has 5,976 active cases from 29 states and Union Territories (UTs) as of June 19

Real estate giant DLF aims to launch Mumbai project by next quarter

DLF to launch Mumbai housing project in next quarter; Goa villa handover likely soon; Privana North sold out with 25% NRI participation and ₹11,000 crore revenue

Lucrative domestic mkt, financial arbitrage attracting UK colleges to India

As of now, at least six major UK universities have announced setting up of campuses or liaison offices in India

DLF sells 1,164 luxury units for ₹11,000 cr in Gurugram's Privana North

Privana North is the third phase of company's 116-acre township in Gurugram

Chandigarh, Punjab among top school education performers, Meghalaya lags

Chandigarh placed in fifth-highest grade in PGI-D 2023-24 for school education, while Punjab and Delhi follow in the seventh level alongside Gujarat, Kerala and others

Class 12 science passouts up 16%, Centre mulls more STEM seats, staff

A rise in science stream students, especially girls, prompts the Centre to seek increased STEM seats, better state-level planning, and expansion of open school systems

Anti-infective drug sales surge in May as fever season grips country

Analysts indicate sales in the segment are expected to grow more during monsoon months

IPO-bound Allchem in legal tussle with Alkem over trademark infringement

IPO-bound Allchem Lifesciences adds legal dispute with Alkem to DRHP as Delhi HC directs both firms to mediation and next hearing is scheduled for 9 July

Serum Institute signs MoU with DNDi to develop dengue treatment candidate

Serum Institute and DNDi sign MoU to develop and scale a dengue monoclonal antibody vaccine with Phase 3 trials in India, Brazil and other endemic countries

Bharat Biotech signs pact with GSK to develop Shigella vaccine candidate

Hyderabad-based Bharat Biotech will lead Phase 3 trials, regulatory progress and manufacturing for Shigella vaccine altSonflex1-2-3 in collaboration with GSK

Tier-2 housing supply falls 35% in Q1 2025, affordable segment hit hardest

New launches in India's top 15 tier 2 cities decline steeply, led by a 54% slump in affordable homes and a shift toward mid- to high-value segments

High temperatures take toll on realty, project timelines, impact workers

Realty & construction cos taking tactical measures: Heatwave training, on-site housing, new tech and more

Germany woos Indian students amid rising uncertainty in US visa policies

Applications to German universities have surged 30% in recent months, with Ambassador Philipp Ackermann citing Germany's appeal amid uncertainty over US student visa rules

AMR crisis: Centre asks states to monitor antibiotic use in animals

Joint working group with CDSCO, state regulators and animal husbandry dept to develop framework for monitoring veterinary antibiotic use amid rising AMR threat

Indo-Pak conflict: FMCG sales soar, auto sector hit in border areas in May

Border tensions in May triggered panic FMCG buying and a dip in vehicle, fuel and cinema sales in Rajasthan, Punjab, Gujarat and J&K, with uneven recovery across sectors

Eli Lilly's weight loss drug Mounjaro sales bulk up 60% on dosage upgrade

It logged value sales worth Rs 12.61 crore in May, compared to Rs 7.88 crore in April.

Covid surge, summer migration may hit project timelines in short term

Developers taking to technology, re-skilling of labour force to address labour shortage issues

Covid booster jab not needed, say experts; high-risk groups need protection

Public health experts recommend a risk-based Covid response focused on the elderly and immunocompromised instead of mass booster vaccination campaigns

Students unsure, experts wary of Trump's Harvard ban despite court stay

Uncertainty clouds US fall intake as Trump's visa ban on Harvard raises fears of wider policy shifts, pushing Indian students to explore alternative destinations

Indian pharma market grows 7.2% in May led by chronic therapies

Indian pharma market grew 7.2% in May with strong performance in chronic therapies such as cardiac and anti-infectives, along with gains from price hikes and new launches